We're building DxMultiomics to be The Central Nexus of Biotech Intelligence. To ensure a seamless experience and continuous improvement, we utilize website analytics. These tools help us monitor site performance, understand how users navigate the platform, and identify opportunities to make your research journey more efficient. We handle this data with the utmost respect for your privacy, and you can choose what works best for you.
TikkunLev Therapeutics is pioneering the development of precision therapies to reverse heart failure by targeting the causal disease biology of failing heart muscle. With a lead program in IND-enabling development for non-ischemic DCM and a broad indication expansion pipeline focused on common, devastating forms of heart failure, TikkunLev is committed to transforming the treatment landscape for heart failure patients worldwide.